Eagle Pharmaceuticals EGRX
$ 2.14
-39.89%
Quarterly report 2023-Q2
added 08-08-2023
Eagle Pharmaceuticals Retained Earnings 2011-2024 | EGRX
Annual Retained Earnings Eagle Pharmaceuticals
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|
112 M | 75.9 M | 84.5 M | 72.5 M | 58.2 M | 26.3 M | -25.7 M | -107 M | -104 M | -102 M | -95.5 M | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
112 M | -107 M | -527 K |
Quarterly Retained Earnings Eagle Pharmaceuticals
2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122 M | 117 M | 112 M | 103 M | 110 M | 120 M | 75.9 M | 82.1 M | 87.7 M | 84.1 M | 84.5 M | 84.5 M | 84.5 M | 84.5 M | 72.5 M | 72.5 M | 72.5 M | 72.5 M | 58.2 M | 58.2 M | 58.2 M | 58.2 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | -25.7 M | -25.7 M | -25.7 M | -25.7 M | -107 M | -107 M | -107 M | -107 M | -110 M | -110 M | -110 M | -110 M | - | -102 M | -102 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
122 M | -110 M | 20.2 M |